
The goal of the study is to evaluate the effectiveness of four drug classes zzso zzso zzso and systemic zzso for zzso zzso experienced by advanced cancer zzso 

A systematic literature review was conducted to July zzso Search sources included zzso zzso zzso zzso and the Cochrane zzso Four zzso selected evidence using zzso criteria: controlled trials not limited to cancer and involving the specified drug classes for zzso zzso 

Three systematic reviews, one with zzso two practice guidelines, and 28 controlled trials were zzso Most examined the effect of zzso generally zzso on zzso Although the results of individual trials were mixed, the systematic review with zzso detected a significant benefit for zzso with systemic zzso two small zzso trials in cancer patients found systemic zzso reduced zzso and zzso also significantly reduced zzso in four zzso zzso zzso zzso was not effective in controlling zzso in any study or the zzso No controlled trials examined systemic zzso in the treatment of cancer patients, and of the other zzso drugs zzso only oral zzso a zzso showed some benefit in the relief of zzso Studies varied in zzso zzso 

zzso zzso administered orally or zzso can be used to manage zzso in cancer zzso zzso zzso may also be used, as a zzso agent if systemic zzso cannot be used or in addition to systemic zzso zzso zzso zzso and zzso are not recommended for the treatment of zzso and zzso must not be used zzso 

